Sugi Predict

Sugi Predict / Compounds / SCHEMBL6669595

SCHEMBL6669595

SCHEMBL6669595

COC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)OC

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ CA14 Q9ULX7 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.37
▸ KMT2A Q03164 2/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ ZDHHC7 Q9NXF8 1/20 0.32
▸ TSHR P16473 2/20 0.32
▸ KEAP1 Q14145 1/20 0.32
▸ NFE2L2 Q16236 1/20 0.32
▸ HCAR2 Q8TDS4 1/20 0.32
▸ LTA4H P09960 1/20 0.31
▸ HIF1A Q16665 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11980977 1.00 SMN1; SMN2 (0.46) SMN1; SMN2CA14ALDH1A1KMT2ACA12
SCHEMBL15541937 1.00 SMN1; SMN2 (0.46) SMN1; SMN2CA14ALDH1A1KMT2ACA12
SCHEMBL31276635 1.00 SMN1; SMN2 (0.46) SMN1; SMN2CA14ALDH1A1KMT2ACA12
SCHEMBL1846267 1.00 SMN1; SMN2 (0.46) SMN1; SMN2CA14ALDH1A1KMT2ACA12
SCHEMBL18383650 0.94 SMN1; SMN2 (0.46) SMN1; SMN2CA14ALDH1A1KMT2ACA12
SCHEMBL29020573 0.92 SMN1; SMN2 (0.40) SMN1; SMN2CA14ALDH1A1KMT2ACA12
SCHEMBL17338688 0.89 PDE4A (0.44) SMN1; SMN2CA14ALDH1A1KMT2ACA12
SCHEMBL6666971 0.89 PDE4A (0.44) SMN1; SMN2CA14ALDH1A1KMT2ACA12
SCHEMBL31324735 0.89 PDE4A (0.44) SMN1; SMN2CA14ALDH1A1KMT2ACA12
SCHEMBL15528782 0.89 PDE4A (0.44) SMN1; SMN2CA14ALDH1A1KMT2ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188048-A1 METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND JIANGSU CELLURANICS NEW MATERIAL TECHNOLOGY CO., LTD. (CN) 2025-06-12 — — US claimed
EP-4477651-A1 METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND Jiangsu Celluranics New Material Technology Co., Ltd. (CN) 2024-12-18 — — EP claimed
CN-116768832-A Preparation method of 2,5-furandicarboxylic acid compound 江苏赛瑞克新材料科技有限公司 2023-09-19 — — CN claimed
WO-2023169517-A1 METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND 江苏赛瑞克新材料科技有限公司 2023-09-14 — — WO claimed
CN-108699225-A The deoxidation of sugar derivatives is dehydrated 加利福尼亚大学董事会 2018-10-23 — — CN claimed
EP-3289000-A1 DEOXYDEHYDRATION OF SUGAR DERIVATIVES The Regents of The University of California (US) 2018-03-07 — — EP claimed
WO-2017147098-A1 DEOXYDEHYDRATION OF SUGAR DERIVATIVES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-08-31 — — WO claimed
WO-2025132660-A1 METHOD FOR TREATING HUMAN PERSPIRATION, AND ASSOCIATED COMPOSITION L'OREAL (FR) 2025-06-26 — — WO disclosed
US-20250188048-A1 METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND JIANGSU CELLURANICS NEW MATERIAL TECHNOLOGY CO., LTD. (CN) 2025-06-12 — — US disclosed
US-20250009621-A1 ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER L'OREAL (FR) 2025-01-09 — — US disclosed
WO-2025006991-A1 ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER L'OREAL (FR) 2025-01-02 — — WO disclosed
EP-4477651-A1 METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND Jiangsu Celluranics New Material Technology Co., Ltd. (CN) 2024-12-18 — — EP disclosed
CN-116768832-A Preparation method of 2,5-furandicarboxylic acid compound 江苏赛瑞克新材料科技有限公司 2023-09-19 — — CN disclosed
US-20090099108-A1 OLIGONUCLEOTIDE DECOYS AND METHODS OF USE UNIVERSITY OF CINCINNATI 2009-04-16 — — US disclosed
US-20090099108-A1 OLIGONUCLEOTIDE DECOYS AND METHODS OF USE UNIVERSITY OF CINCINNATI 2009-04-16 — — US disclosed
EP-0831767-B1 ALPHA HYDROXYACID ESTERS FOR SKIN AGING YU RUEY J (US) 2004-09-22 — — EP disclosed
EP-0831767-A4 ALPHA HYDROXYACID ESTERS FOR SKIN AGING YU RUEY J (US) 2000-05-17 — — EP disclosed
EP-0831767-A1 ALPHA HYDROXYACID ESTERS FOR SKIN AGING Yu, Ruey J., Dr. (US) 1998-04-01 — — EP disclosed
US-5686489-A TOPICALLY APPLIED TO INDUCE GLYCOSAMINOGLYCAN, PROTEOGLYCAN, COLLAGEN AND ELASTIN BIOSYNTHESIS; WRINKLE RESISTANCE TRISTRATA TECHNOLOGY, INC. (US) 1997-11-11 — — US disclosed
WO-1996040047-A1 ALPHA HYDROXYACID ESTERS FOR SKIN AGING YU RUEY J (US) 1996-12-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250009621-A1 ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER EBP, ADH1A, ADH1C SMN1; SMN2 3977/4885CA14 2146/4885ALDH1A1 119/4885
US-20090099108-A1 OLIGONUCLEOTIDE DECOYS AND METHODS OF USE NFKB2, IKBKB, NFKBIA SMN1; SMN2 355/4885CA14 3846/4885ALDH1A1 2564/4885
US-20250188048-A1 METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND HPD, DPYD, PGD SMN1; SMN2 4474/4885CA14 913/4885ALDH1A1 624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.